Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mainphar
Mainaschaff, Bavaria, Germanymainphar.de ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Mainphar is a German pharmaceutical company specializing in the development, marketing, and distribution of generic medicinal products. Based in Mainaschaff, the company focuses on providing high-quality, cost-effective therapeutic options across various indications, including pain management and general medicine. Mainphar operates primarily within the German healthcare market, supplying pharmacies and wholesalers with a portfolio of established small molecule drugs. Their business model emphasizes reliable supply chains and the commercialization of off-patent pharmaceuticals. The company maintains a lean organizational structure to remain agile and competitive in the generic drug sector.
- Therapeutic areas
- Infectious DiseasesGastroenterologyNeurologyImmunology
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on Mainphar.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mainphar.